DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
INFA Informatica
- 19.750
- -5.420-21.53%
Close Feb 14 16:00 ET
- 19.500
- -0.250-1.27%
Post 20:01 ET
5.99BMarket Cap658.33P/E (TTM)
19.900High16.370Low27.95MVolume16.670Open25.170Pre Close503.61MTurnover15.86%Turnover Ratio658.33P/E (Static)303.54MShares39.80052wk High2.60P/B3.48BFloat Cap16.37052wk Low--Dividend TTM176.28MShs Float40.130Historical High--Div YieldTTM14.03%Amplitude13.290Historical Low18.018Avg Price1Lot Size
Informatica Stock Forum
Sign in to post a comment
$Informatica (INFA.US)$ was earnings report that bad?
1
$Informatica (INFA.US)$ sank more than 30% after hours Thursday after the enterprise cloud data-management company missed analyst estimates for its Q4 revenues and issued forward guidance below what the market had been expecting.
INFA fell 30.6% to $17.48 shortly after 5:30 p.m. ET after the company reported $428.3 million in quarterly revenue, trailing the $457 million that analysts' consensus estimate reportedly called...
INFA fell 30.6% to $17.48 shortly after 5:30 p.m. ET after the company reported $428.3 million in quarterly revenue, trailing the $457 million that analysts' consensus estimate reportedly called...
2
1
$Informatica (INFA.US)$ good time to grab some , SA projects coming in big waves
3
$Informatica (INFA.US)$ why did this stock go up but $Salesforce (CRM.US)$ went down after announcement of acquisition was released?!! 🤔🤔🤔
1
CEO Amit Walia says the company is successfully implementing its strategy of selling only cloud-based software to new customers. He also sees generative AI software for enterprise applications as a natural fit for Informatica's business.
1
Despite Informatica's muted growth estimates, its P/S ratio matches its industry peers, indicating potential overlooked risks. Low revenue growth could negatively impact sentiment and result in falling share prices.
Insider selling activity and lack of stock purchases raise caution in the company. Despite this, it's crucial to do your own research before investing.
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Clorox (CLX.US)$ - up 4.6%
2. $Cognizant (CTSH.US)$ - up 4.1%
3. $Informatica (INFA.US)$ - up 2.8%
4. $Kanzhun (BZ.US)$ - up 2.7%
5. $Sunrun (RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals (REGN.US)$ - up 1.9%
7. $McKesson (MCK.US)$ - up 1.9%
8. $Curtiss-Wright (CW.US)$ - up 1.7%
9. $MercadoLibre (MELI.US)$ - up 1.5...
Gap Ups
1. $Clorox (CLX.US)$ - up 4.6%
2. $Cognizant (CTSH.US)$ - up 4.1%
3. $Informatica (INFA.US)$ - up 2.8%
4. $Kanzhun (BZ.US)$ - up 2.7%
5. $Sunrun (RUN.US)$ - up 2.6%
6. $Regeneron Pharmaceuticals (REGN.US)$ - up 1.9%
7. $McKesson (MCK.US)$ - up 1.9%
8. $Curtiss-Wright (CW.US)$ - up 1.7%
9. $MercadoLibre (MELI.US)$ - up 1.5...
+16
21
10
Upgrades
• $AutoZone (AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy (CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision (EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care (FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab (GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
• $AutoZone (AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy (CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision (EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care (FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab (GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
22
4
No comment yet
Matrix 404 : 15 probably